Clair is your AI-enhanced senior scientist: any sample from intake to interpretation at the principal bar, at a fraction of the cost, built to augment principal scientists rather than replace them.

Autonomous omicsBuilt by scientistsSan Francisco / clair.bio
Senior-scientist omics, autonomous

A clean read on the biology you're changing.

Clair is your AI-enhanced senior scientist: any sample, from intake to interpretation, at the principal bar and a fraction of the cost of another senior hire. It doesn't replace your experts; it takes the repetitive, high-stakes work off their hands so their time goes to the science only they can do.

Start a projectSee how it works
4055%
lower cost than an in-house senior scientist
~5×
faster. 1 week, not 4-6
Seniorbar
principal-scientist QC, held or beaten
01The bottleneck

The judgment that makes an assay work rarely reaches the protocol.

It is tacit, held in a few senior scientists' hands, and it leaves when they do. The market is fragmented too: one vendor dissociates, another sequences, another analyzes, and you stitch it together, losing signal at every seam. Getting to viable single cells alone is where many experiments quietly die.

02The service

One chain. One owner. The senior bar, start to finish.

Hand Clair any input, embryo, tissue, fresh, frozen, or cells, and get back integrated, interpreted signal. Every project starts by fixing the statistical framework and replicate design, then runs end to end on commercial kits or Clair's own low-cost chemistry. The specialty is low-input and no-kit methods, the finicky work a commodity shop can't take.

Low-input CUT&Tag / TIP-seqLow-input RNA-seq (Smart-seq3 / FLASH-seq)ATAC-seqMultiomeWGSDNA-seq+ methods with no kit
01
Sample intake
any input
02
Library prep
kit or DIY
03
Sequencing
tracked E2E
04
Analysis
predetermined stats
05
Interpretation
with you

Fragmented vendors lose signal at every seam. Clair owns the whole chain, so the biology survives.

03The economics

Hold the kit price flat, and the entire cut is senior time.

In-house senior scientist100% baseline
Senior labor 65%
Reagents
Seq
Clair, kit parity~61% cost, ~39% cut
Clair fee
Reagents
Seq
labor collapsed, saved
Senior labor (the cut)Clair feeReagents (pass-through)Sequencing (pass-through)

Senior labor is ~65% of the true cost of these skilled assays. Automation collapses it while the judgment stays encoded. Clair's DIY kits shrink the reagent block too, widening the cut to ~55%+. Turnaround (1 week vs 4-6) is a separate throughput multiplier.

04The principle

Augment the expert. Never replace them.

Clair does not replace your principal scientists. It takes the repetitive, high-stakes work off their plate, the boring parts that still must be done exactly right, for less than another senior hire. Their time goes back to the science only they can do.

05Why now
Reprogramming is in the clinic
The field bets aging is epigenetic, yet cannot reliably read the state it is reprogramming.
LLMs can drive lab hardware
Agents can now reason over an assay and physically execute it, end to end.
Sequencing is too cheap to meter
So the skilled hands behind library prep are the real bottleneck.
06The mission
Solve the fundamental inefficiency in biology.

Wet-lab R&D is still bound to one skilled human per role, because the judgment that makes an assay work never reached the protocol. Encode it and the ratio inverts: a 50-person lab becomes ~20 machines and one supervising scientist. Autonomous science, made real.

Bring Clair your hardest sample.
Start a project
Clair / clair.bio / San Francisco / Autonomous omics